Related Experiment Video
Updated: May 15, 2025
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
An automated cascade framework for glioma prognosis via segmentation, multi-feature fusion and classification
Meriem Hamoud1, Nour El Islem Chekima2, Abdelkader Hima3
1LIAP Laboratory, University of El Oued, PO Box 789, El Oued, 39000, Algeria.
Abstract:
Glioma is one of the most lethal types of brain tumors, accounting for approximately 33% of all diagnosed brain tumor cases. Accurate segmentation and classification are crucial for precise glioma characterization, emphasizing early detection of malignancy, effective treatment planning, and prevention of tumor progression. Magnetic Resonance Imaging (MRI) serves as a non-invasive imaging modality that allows detailed examination of gliomas without exposure to ionizing radiation. However, manual analysis of MRI scans is impractical, time-consuming, subjective, and requires specialized expertise from radiologists. To address this, computer-aided diagnosis (CAD) systems have greatly evolved as powerful tools to support neuro-oncologists in the brain cancer screening process. In this work, we present a glioma classification framework based on 3D multi-modal MRI segmentation using the CNN models SegResNet and Swin UNETR which incorporates transformer mechanisms for enhancing segmentation performance. MRI images undergo preprocessing with a Gaussian filter and skull stripping to improve tissue localization. Key textural features are then extracted from segmented tumor regions using Gabor Transform, Discrete Wavelet Transform (DWT), and deep features from ResNet50. These features are fused, normalized, and classified using a Support Vector Machine (SVM) to distinguish between Low-Grade Glioma (LGG) and High-Grade Glioma (HGG). Extensive experiments on benchmark datasets, including BRATS2020 and BRATS2023, demonstrate the effectiveness of the proposed approach. Our model achieved Dice scores of 0.815 for Tumor Core, 0.909 for Whole Tumor, and 0.829 for Enhancing Tumor. Concerning classification, the framework attained 97% accuracy, 94% precision, 96% recall, and a 95% F1-score. These results highlight the potential of the proposed framework to provide reliable support for radiologists in the early detection and classification of gliomas.
